Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

229 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

NCT00322491

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UCLA School of Medicine Loa Angeles, California, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

NCT00322387

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Indiana Blood and Marrow Transplantation Beech Grove, Indiana, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

NCT00103610

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • City of Hope Samaritan Bone Marrow Transplant Program Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 32 locations
View Trial Details
Completed

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

NCT00094848

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering New York, United States
View Trial Details
Completed

Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma

NCT00283985

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Département Maladies du Sang Angers, France
  • CH Annecy Annecy, France
  • Service de Radiothérapie, Polyclinique Bordeaux Nord Bordeaux, France
  • CHU Bordeaux Bordeaux, France
View all 25 locations
View Trial Details

Related conditions